Severe Acute Respiratory Syndrome (SARS) Treatment Market Analysis By Drug Type(Antiviral, Antibacterial, Immunomodulators Drugs), By Route Of Administration(Oral, Injectable) & Forecast 2023-2032
The global severe acute respiratory syndrome (SARS) treatment market size was valued at USD 25.7 billion in 2021 and is projected to reach around USD 8.2 billion in 2030 exhibiting a CAGR of 14.5% in the forecasted period. The rising cases of COVID-19, increase in the number of numerous contagious diseases caused by coronavirus are some of the key factors anticipated to drive the market. Additionally, fast expansion of the elderly population together with favourable government policies and initiatives for confirming cautionary treatments is projected to drive expansion of the global severe acute respiratory syndrome treatment market in the upcoming years. On the other hand, unavailability of medications during the pandemic and higher prices than actual cost for the treatment are anticipated to hinder the growth of severe acute respiratory syndrome (SARS) treatment market growth. https://wemarketresearch.com/r....eports/severe-acute-
